Brenntag Specialties has acquired Czech-based mcePharma, strengthening its position in the pharma and biopharma industries through expanded continuous monitoring platform (CMP) capabilities and a more strategic presence in central Europe. The acquisition will enable Brenntag to develop a central hub for good manufacturing practice (GMP) value-added services across Europe, the Middle East and Africa (EMEA), […]
The post Brenntag acquires mcePharma to expand GMP capabilities in biopharma services appeared first on Pharmafile.
